Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
05/2013
05/23/2013US20130131119 N-[(het)arylethyl)] pyrazole(thio)carboxamides and their heterosubstituted analogues
05/23/2013US20130131114 Novel alkene oxindole derivatives
05/23/2013US20130131093 Novel Dihydropyrimidin-2(1H)-One Compounds As Neurokinin-3 Receptor Antagonists
05/23/2013US20130131062 Pyridazinones and furan-containing compounds
05/23/2013US20130131061 Novel Estrogen Receptor Ligands
05/23/2013US20130131040 Pyrazine kinase inhibitors
05/23/2013US20130129795 Inhibition and dispersion of bacterial biofilms with imidazole-triazole derivatives
05/23/2013US20130129677 Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections
05/23/2013US20130126856 Compound having indenocarbazole ring structure, and organic electroluminescent device
05/23/2013CA2856103A1 Morpholinyl benzotriazine for use in cancer therapy
05/23/2013CA2853340A1 Substituted 1,2,5-oxadiazole compounds and their use as herbicides ii
05/22/2013EP2594565A2 2-acylaminopropanol-type glucosylceramide synthase inhibitors
05/22/2013EP2594564A2 2-acylaminopropanol-type glucosylceramide synthase inhibitors
05/22/2013EP2594563A2 2-acylaminopropanol-type glucosylceramide synthase inhibitors
05/22/2013EP2594562A2 2-acylaminopropanol-type glucosylceramide synthase inhibitors
05/22/2013EP2593447A2 New heterocyclic compounds as pesticides
05/22/2013EP2592934A1 Novel dihydropyridin-2(1h)-one compounds as s-nitrosoglutathione reductase inhibitors and neurokinin-3 receptor antagonists
05/22/2013EP2592933A1 Mif inhibitors and their uses
05/22/2013CN103119027A Substituted phenylacetate and phenylpropane amides and use thereof
05/22/2013CN103113360A Atorvastatin derivative, pharmaceutical composition and pharmaceutical applications thereof
05/22/2013CN103113301A Thiourea huperzine A compound and preparation method of compound as well as application of compound in pesticides
05/22/2013CN102285945B Method for preparing alpha-carbonyl epoxy compound
05/22/2013CN102134214B Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
05/22/2013CN102001987B Heteroarylamine compound, organic light-emitting device and panel display device
05/22/2013CN101835756B 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive MGLUR2 -receptor modulators
05/22/2013CN101687786B Hydroxylamine compounds and methods of their use
05/22/2013CN101316823B 2,4,5-triphenyl imidazoline derivatives as inhibitors of interaction between p53 and MDM2 proteins for use as anticancer agents
05/21/2013US8445694 Hydrazonopyrazole derivatives and their use as therapeutics
05/21/2013US8445684 Nicotinic acetylcholine receptor ligands and the uses thereof
05/21/2013US8445683 Porphyrin compounds comprising one or more pyridone moieties
05/21/2013US8445514 Urotensin II receptor antagonists
05/21/2013US8445477 Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/21/2013CA2560162C Inhibitors of iap
05/21/2013CA2396688C Glycosidase inhibitors and methods of synthesizing same
05/16/2013WO2013071203A1 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (fprl-1) receptor modulators
05/16/2013WO2013071093A1 Pyrazine compounds useful as inhibitors of atr kinase
05/16/2013WO2013071085A1 Pyrazine compounds useful as inhibitors of atr kinase
05/16/2013WO2013068875A1 2-thiopyrimidinones
05/16/2013WO2013068554A1 New cyclohexylamine derivatives having beta 2 adrenergic agonist and m3 muscarinic antagonist activities
05/16/2013WO2013068552A1 NEW CYCLOHEXYLAMINE DERIVATIVES HAVING β2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES
05/16/2013WO2012054721A8 Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitors
05/16/2013US20130123507 Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof
05/16/2013US20130123304 Pyridine non-classical cannabinoid compounds and related methods of use
05/16/2013US20130123265 Compounds that modulate intracellular calcium
05/16/2013US20130123259 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-ones and derivatives thereof as kinase inhibitors
05/16/2013US20130123252 2,3,5-Trisubstituted Thiophene Compounds and Uses Thereof
05/16/2013US20130123243 Diamine derivatives as inhibitors of leukotriene a4 hydrolase
05/16/2013US20130123242 Compounds and methods for the treatment or prevention of flavivirus infections
05/16/2013US20130123234 Aryl- or Heteroaryl-Substituted Benzene Compounds
05/16/2013US20130123233 Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2013US20130123230 2-Thiopyrimidinones
05/16/2013US20130123215 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (fprl-1) receptor modulators
05/16/2013US20130123106 Novel nicotine derivatives
05/16/2013CA2855390A1 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (fprl-1) receptor modulators
05/16/2013CA2853024A1 2-thiopyrimidinones
05/16/2013CA2849872A1 New cyclohexylamine derivatives having .beta.2 adrenergic agonist and m3 muscarinic antagonist activities
05/16/2013CA2849868A1 New cyclohexylamine derivatives having .beta.2 adrenergic agonist and m3 muscarinic antagonist activities
05/15/2013EP2592905A1 Compound, charge transporting material and organic electroluminescent element
05/15/2013EP2592078A1 New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
05/15/2013EP2592077A1 New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
05/15/2013EP2592074A1 Thioxanthone-4-carboxylates, their preparation methods, photoinitiator compositions and uses thereof
05/15/2013EP2590950A1 N-cyclyl-3 - (cyclylcarbonylaminomethyl) benzamide derivatives as rho kinase inhibitors
05/15/2013EP2590944A1 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators
05/15/2013CN103102232A Styryl-based compound, composition containing styryl-based compound, and organic light emitting diode including styryl-based compound
05/14/2013US8440842 Antimicrobial compounds, their synthesis and their use for treatment of mammalian infections
05/14/2013US8440639 Combination compositions for reducing intraocular pressure
05/14/2013CA2716369C Phenoxypropylamine compounds
05/14/2013CA2583333C Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
05/14/2013CA2546657C 6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
05/14/2013CA2532965C 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
05/10/2013WO2013067267A1 Rod -like hepatitis c virus inhibitors containing the fragement {2- [4- (bi phenyl - 4 - yl) - 1h - imidazo - 2 - yl] pyrrolidine - 1 - carbonlymethyl} amine
05/10/2013WO2013065835A1 Pharmaceutical composition for treating diabetes
05/10/2013WO2013065065A1 Optically active fluconazole analogues containing thiophenes as antifungal agents
05/10/2013WO2013064519A1 Pesticidal compounds
05/10/2013WO2013064461A2 Compounds with nematicidal activity
05/10/2013WO2013006308A3 Dihydropyrazoles, pharmaceutical compositions thereof and their use for the treatment of fertility disorders
05/10/2013WO2012158413A3 Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
05/10/2013CA2855641A1 Optically active fluconazole analogues containing thiophenes as antifungal agents
05/10/2013CA2852700A1 Rod-like hepatitis c virus inhibitors containing the fragment {2-[4-(biphenyl-4-yl)-1h-imidazo-2-yl]pyrrolidine-1-carbonlymethyl}amine
05/09/2013US20130116444 Process for cabazitaxel, and intermediates thereof
05/09/2013US20130116430 Novel nicotinamide derivative or salt thereof
05/09/2013US20130116284 Lipoic acid and nitroxide derivatives and uses thereof
05/09/2013US20130116283 Substituted indole derivatives
05/09/2013US20130116247 IRE-1alpha INHIBITORS
05/09/2013US20130116230 3-aminopyrrolidine derivatives as modulators of chemokine receptors
05/09/2013US20130116229 Novel inhibitor compounds of phosphodiesterase type 10a
05/09/2013US20130113367 Heterocyclic compound and organic light-emitting device including the same
05/09/2013US20130112954 Dibenzo[f,h]Quinoxaline Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device
05/09/2013US20130112948 Heterocyclic compound and organic light-emitting diode including the same
05/08/2013EP2589600A1 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
05/08/2013EP2589595A1 Agent for treating hcv infection
05/08/2013EP2589591A1 Compound with carbazole ring structure and organic electroluminescent element
05/08/2013EP2588475A1 Apoptosis signal-regulating kinase inhibitors
05/08/2013EP2588471A1 Heterocyclic compounds and their use as inhibitors of pi3k activity
05/08/2013EP2588451A1 Piperidine derivatives and their use for the treatment of metabolic disorders
05/08/2013CN103097354A Substituted benzamide compounds
05/08/2013CN103087052A Thiophene derivatives and medicinal use thereof
05/08/2013CN103087051A Synthesis and application of coumarin type dye sensitizer
05/08/2013CN103087045A Benzimidazole heterocyclic compound, pharmaceutical composition and application thereof
05/08/2013CN103087044A Method for preparing benzimidazole heterocyclic compound
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 523